探索药物监督中不成比例性分析的复杂性:对READUS-PV指南的反思和呼吁采取行动
Tarek A Hammad1, Melissa Naylor2, Dona M Ely3
1Medical Safety of Marketed Products Development and Plasma-Derived Therapies, Patient Safety and Pharmacovigilance, Takeda Development Center Americas, Inc., Cambridge, MA, United States.
Frontiers in pharmacology
|April 24, 2025
概括
不成比例分析 (DA) 用于检测不良事件 (AE) 信号是受欢迎的,但有局限性. 一项新的指导方针改善了报告,但需要一个联盟来负责任地验证和共享信号,以防止误解.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 监管科学 监管科学
背景情况:
- 不成比例分析 (DA) 广泛用于检测自发不良事件 (AE) 数据中不成比例报告 (SDR) 的安全信号.
- 该READUS-PV指南旨在标准化基于DA的出版物的报告,解决该领域的一致性需求.
- 尽管取得了进展,但DA数据源,分析方法和结果解释的固有局限性仍然存在.
研究的目的:
- 讨论药物监督中不成比例性分析的局限性.
- 要突出与过早公布来自自发报告的安全信号相关的挑战.
- 评估READUS-PV指南在改善DA结果解释方面的有效性,并提出未来的方向.
主要方法:
- 对药物监督中不成比例性分析方法的批判性审查.
- 对自发不良事件数据和报告中固有的局限性的分析.
- 评估READUS-PV指南对DA结果解释的影响.
主要成果:
- 不成比例分析由于数据源,分析方法和可解释性问题而面临重大限制,导致潜在的噪音和错误信号.
- 该READUS-PV指南为标准化提供了一个步骤,但并不能完全解决DA固有的挑战.
- 安全信号的过早发布可能会导致不必要的警报和误解.
结论:
- 对安全信号的有效报告是不够的;强有力的验证至关重要.
- 需要包括监管机构,学术界和行业在内的协调努力,以建立负责验证和共享安全信号数据的标准.
- 建议成立一个财团,为共享安全信号信息制定明确的科学界限,防止公众发出警觉.
相关概念视频
01:19Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
01:12Analysis of Population Pharmacokinetic Data
195
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
195
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:20Volume of Distribution
66
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
66
01:25Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
27
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
27